NEKISHA BAILEY: Open Payments
NPI 1235795451 · DETROIT, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$970 in 9 payments from 6 companies in 2025. Trend: 2023 $149 · 2024 $333 · 2025 $970
Food & beverage: $970
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 2 | $240 |
| Braeburn Inc. | 2 | $221 |
| Alkermes, Inc. | 2 | $140 |
| GENZYME CORPORATION | 1 | $126 |
| Teva Pharmaceuticals USA, Inc. | 1 | $122 |
| E.R. Squibb & Sons, L.L.C. | 1 | $121 |
Products named: Auvelity, BRIXADI, CEREZYME, AUSTEDO XR, LYBALVI, COBENFY, ARISTADA.
Industry payments across MI — which companies pay providers there.
